BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET StudyThomas Kaley, David M. Hyman, Bethany Pitcher et al.|Journal of Clinical Oncology|2018Cited by 330
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)Anne Brédart, Neil K. Aaronson, Andrew Bottomley et al.|European Journal of Cancer|2005Cited by 241
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancerThomas Powles, Dónal Landers, Danielle Carroll et al.|Nature Medicine|2021Cited by 115
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II studyF. Mouriaux, Florence Joly, Vincent Servois et al.|British Journal of Cancer|2016Cited by 48
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatmentGiulia Binarelli, Marie Lange, Mylène Duivon et al.|Expert Review of Neurotherapeutics|2023Cited by 31